NCT06376175

Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program

Name: Clinical Trial NCT06376175
Creator: Lumos Labs, Inc.
Keywords: Healthy Adults, clinical trial, United States of America

Task Atlas: An Observational Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program

Lumos Labs, Inc.·ClinicalTrials.govNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Healthy Adults
Study type: Observational

Sponsor & location

Primary sponsor: Lumos Labs, Inc.
Location: Sacramento, United States of America

Timeline & enrollment

Phase: N/A
Start date: Apr 15, 2024
End date: Aug 31, 2024
Enrollment: 40 participants

Primary outcome

BOLD response during gameplay,Responder rates,Structural MRI volumetrics: Volume,Structural MRI volumetrics: Cortical thickness,Structural MRI volumetrics: Brain-Predicted Age Difference,Behavior response: Game score,BAMS-7 (Brief Attention and Mood Scale of 7 Items),VGPQ (Video Game Playing Questionnaire)

Summary

Healthy volunteers ages 25-40 from the general US population who meet the eligibility criteria and are enrolled will (a) play Lumosity games at least 20 times each in under 60 days and (b) then complete one session of task-based functional magnetic resonance imaging (fMRI) while playing Lumosity games.

ICD-10 classifications

ObesityHealthy person accompanying sick personObesity, unspecifiedRoutine general health check-up of inhabitants of institutionsLifestyle-related condition

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06376175
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06376175 through Pure Global AI's free database. This phase not specified trial is sponsored by Lumos Labs, Inc. and is currently Not yet recruiting. The study focuses on Healthy Adults. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.